Location of Repository

An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses

By Chris D. Bailey, Richard Wagland, Rasha Dabbour, Ann Caress, Jaclyn Smith and Alex Molassiotis

Abstract

Background: breathlessness is a debilitating and distressing symptom in a wide variety of diseases and still a difficult symptom to manage. An integrative review of systematic reviews of non-pharmacological and pharmacological interventions for breathlessness in non-malignant disease was undertaken to identify the current state of clinical understanding of the management of breathlessness and highlight promising interventions that merit further investigation.<br/><br/>Methods: systematic reviews were identified via electronic databases between July 2007 and September 2009. Reviews were included within the study if they reported research on adult participants using either a measure of breathlessness or some other measure of respiratory symptoms.<br/><br/>Results: in total 219 systematic reviews were identified and 153 included within the final review, of these 59 addressed non-pharmacological interventions and 94 addressed pharmacological interventions. The reviews covered in excess of 2000 trials. The majority of systematic reviews were conducted on interventions for asthma and COPD, and mainly focussed upon a small number of pharmacological interventions such as corticosteroids and bronchodilators, including beta-agonists. In contrast, other conditions involving breathlessness have received little or no attention and studies continue to focus upon pharmacological approaches. Moreover, although there are a number of non-pharmacological studies that have shown some promise, particularly for COPD, their conclusions are limited by a lack of good quality evidence from RCTs, small sample sizes and limited replication.<br/><br/>Conclusions: more research should focus in the future on the management of breathlessness in respiratory diseases other than asthma and COPD. In addition, pharmacological treatments do not completely manage breathlessness and have an added burden of side effects. It is therefore important to focus more research on promising non-pharmacological intervention

Topics: RT
Year: 2010
OAI identifier: oai:eprints.soton.ac.uk:176315
Provided by: e-Prints Soton

Suggested articles

Preview

Citations

  1. (2007). AB: Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database of Systematic Reviews doi
  2. (2005). Action plans for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  3. (2007). Activity limitation and quality of life in COPD. doi
  4. (2003). Acupuncture for chronic asthma. Cochrane Database of Systematic Reviews doi
  5. (1997). AD: Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet doi
  6. (2004). Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Cochrane Database of Systematic Reviews doi
  7. (2003). Allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews doi
  8. (2005). Alpers JH: Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  9. (2001). Alpers JH: Mucolytics for bronchiectasis. Cochrane Database of Systematic Reviews doi
  10. (1999). American Thoracic Society: Dyspnea: mechanisms, assessment, and management: a consensus statement. doi
  11. (2003). Anami K: Oxatomide for stable asthma in adults and children. Cochrane Database of Systematic Reviews doi
  12. (2004). Anticholinergic agents for chronic asthma in adults. Cochrane Database of Systematic Reviews doi
  13. (2001). Anticholinergic therapy for bronchiectasis. Cochrane Database of Systematic Reviews doi
  14. (2005). AP: Manual therapy for asthma. Cochrane Database of Systematic Reviews doi
  15. (2004). Ardern KD: Dietary salt reduction or exclusion for allergic asthma. Cochrane Database of Systematic Reviews doi
  16. (2001). Ardern KD: Tartrazine exclusion for allergic asthma. Cochrane Database of Systematic Reviews doi
  17. (1999). Beclomethasone at different doses for chronic asthma. Cochrane Database of Systematic Reviews doi
  18. (2000). BH: Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database of Systematic Reviews doi
  19. (2001). BH: Antibiotics for acute asthma. Cochrane Database of Systematic Reviews doi
  20. (2003). BH: Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database of Systematic Reviews doi
  21. (2006). BH: Heliox for nonintubated acute asthma patients. Cochrane Database of Systematic Reviews doi
  22. (2000). BH: Inhaled steroids for acute asthma following emergency department discharge. Cochrane Database of Systematic Reviews doi
  23. (2003). BH: Mast-cell stabilising agents to prevent exercise-induced broncho-constriction. Cochrane Database of Systematic Reviews doi
  24. (2002). BH: Nedocromil sodium for preventing exercise-induced broncho-constriction. Cochrane Database of Systematic Reviews doi
  25. (2000). BH: Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced broncho-constriction in asthmatics. Cochrane Database of Systematic Reviews doi
  26. (2006). Black PN: Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  27. (2000). Budesonide at different doses for chronic asthma. Cochrane Database of Systematic Reviews doi
  28. (2003). Calorie controlled diet for chronic asthma. Cochrane Database of Systematic Reviews doi
  29. Camargo CA Jr: Methylxanthines for exacerbations of chronic obstructive pulmonary disease. doi
  30. (2002). Cardioselective betablockers for reversible airway disease. Cochrane Database of Systematic Reviews doi
  31. (2000). Cates CJ: Alexander technique for chronic asthma. Cochrane Database of Systematic Reviews doi
  32. (2005). Cates CJ: Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database of Systematic Reviews doi
  33. (2005). Cates CJ: Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews doi
  34. (2006). Cates CJ: Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  35. (2003). Cates CJ: Ionisers for chronic asthma. Cochrane Database of Systematic Reviews doi
  36. (2006). Cates CJ: Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  37. (1998). CCJL: The global burden of disease, 1990-2020. Nat Med doi
  38. (2003). CD: Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  39. (2002). Cendon S: Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  40. (2000). CJ: Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database of Systematic Reviews doi
  41. (1995). Coats AJS: Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur Heart J doi
  42. (2004). Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  43. (2003). Contardi L-A H: Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma -A systematic review. Chest
  44. (2007). COPD and coping with breathlessness at home: a review of the literature. doi
  45. (2001). Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database of Systematic Reviews doi
  46. (2008). Currow D: Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews doi
  47. (2001). Dartigues JF: Dyspnea and 8-year mortality among elderly men and women: the PAQUID cohort study. doi
  48. (2003). DR: Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomised controlled trials. doi
  49. (2005). DS: Prognostic significance of dyspnea in patients referred for cardiac stress testing. doi
  50. (2005). Ducharme FM: Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database of Systematic Reviews doi
  51. (2005). Ducharme FM: Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database of Systematic Reviews doi
  52. (2000). Dyspnoea and cough.
  53. (2008). Dyspnoea versus fatigue: additional prognostic information from symptoms in chronic heart failure? doi
  54. (2001). EA: Caffeine for asthma. Cochrane Database of Systematic Reviews doi
  55. (2008). Effects of inspiratory muscle training in cystic fibrosis. Clin Rehabil doi
  56. (2006). EH: Anti-IgE for chronic asthma in adults and children. Cochrane Database of Systematic Reviews doi
  57. (2003). EH: Azathioprine as an oral corticosteroid sparing agent for asthma. Cochrane Database of Systematic Reviews doi
  58. (2003). EH: Chloroquine as a steroid sparing agent for asthma. Cochrane Database of Systematic Reviews doi
  59. (2003). EH: Colchicine as an oral corticosteroid sparing agent for asthma. Cochrane Database of Systematic Reviews doi
  60. (2002). EH: Dapsone as an oral corticosteroid sparing agent for asthma. Cochrane Database of Systematic Reviews doi
  61. (2001). EH: Heliox for treatment of exacerbations of chronic obstructive pulmonarydisease. Cochrane Database of Systematic Reviews doi
  62. (0031). EH: Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews, doi
  63. (2006). EH: Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews doi
  64. (2002). EH: Nebulised morphine for severe interstitial lung disease. Cochrane Database of Systematic Reviews doi
  65. (2005). EH: Prostacyclin for pulmonary hypertension in adults. Cochrane Database of Systematic Reviews doi
  66. (2002). EH: Self-management education and regular practitioner review for adults with asthma. Cochrane Database of Systematic Reviews doi
  67. (2006). Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database of Systematic Reviews doi
  68. (2005). Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med doi
  69. (2003). F: Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews doi
  70. (2002). Fay JK: Primary care based clinics for asthma. Cochrane Database of Systematic Reviews doi
  71. (2000). Feather versus non-feather bedding for asthma. Cochrane Database of Systematic Reviews doi
  72. (2006). Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children. Cochrane Database of Systematic Reviews doi
  73. (2004). FM: Addition of inhaled longacting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Cochrane Database of Systematic Reviews doi
  74. (2002). FSF: Short-acting beta2-agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  75. (2006). FSF: Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax doi
  76. (2004). FSF: Written individualised management plans for asthma in children and adults. Cochrane Database of Systematic Reviews doi
  77. (2001). Fusco F: Respiratory problems in advanced cancer. Support Care Cancer doi
  78. (2005). GR: Evaluation of chronic dyspnea. Am Fam Physician
  79. (2006). Greenstone M: Inhaled hyperosmolar agents for bronchiectasis (Review). Cochrane Database of Systematic Reviews doi
  80. (2000). Greenstone MA: How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax doi
  81. (2007). Gulsvik A: Respiratory symptoms and long-term cardiovascular mortality. Respir Med doi
  82. (2001). GW: Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews doi
  83. (2008). Hanania NA: Anxiety and depression in COPD. Chest
  84. (2007). Higgins IJ: Measurement of breathlessness in advanced disease: a systematic review. Resp Med doi
  85. (2001). Home care by outreach nursing for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  86. (2003). Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  87. (2002). Humidity control for chronic asthma. Cochrane Database of Systematic Reviews doi
  88. (2005). I: A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma. Health Technol Assess doi
  89. (2006). IJ: A Comparison of Symptom Prevalence doi
  90. (2008). IJ: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases (Review). Cochrane Database of Systematic Reviews doi
  91. (2008). IJ: The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nature Clin Pract doi
  92. (2006). Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database of Systematic Reviews doi
  93. (2001). Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  94. (2000). Inhaled steroids for bronchiectasis. Cochrane Database of Systematic Reviews doi
  95. (2006). Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  96. (2005). Inspiratory muscle training in adults with chronic obstructive pulmonary disease: A systematic review. Respir Med doi
  97. (2008). Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med doi
  98. (2006). Ipratropium bromide versus long acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  99. (2006). Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  100. (2003). JL: Gastro-oesophageal reux treatment for asthma in adults and children. Cochrane Database of Systematic Reviews doi
  101. (2002). KE: A systematic review of the use of opioids in the management of dyspnoea. Thorax
  102. (2002). Kerstjens HAM: A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest
  103. (1996). Kradin RL: Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. doi
  104. (2002). Kwakkel R: Gosselink: Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J doi
  105. (2009). LaPoe A: Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence. Cardiopulmon Phy Ther J
  106. (2004). Lasserson TJ: Homeopathy for chronic asthma. Cochrane Database of Systematic Reviews doi
  107. (2007). Lasserson TJ: Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  108. (2001). Livesley B: The need for palliative care for patients with non-cancer diseases: a review of the evidence. doi
  109. (2006). Long- and Short-Acting Inhaled Beta~2-Agonists: Do BenefitRisk-Ratios Differ in the Treatment of Bronchial Asthma and COPD? Z Allg Med
  110. (2006). Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2005, CD005076. Bailey et al. doi
  111. (2001). Long-acting beta2-agonists for bronchiectasis. Cochrane Database of Systematic Reviews doi
  112. (2007). Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database of Systematic Reviews doi
  113. (2003). Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database of Systematic Reviews doi
  114. (1999). Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema. Thorax doi
  115. (2000). Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database of Systematic Reviews doi
  116. (1998). Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database of Systematic Reviews doi
  117. (2002). MJ: Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database of Systematic Reviews doi
  118. (2004). ML: House dust mite control measures for asthma. Cochrane Database of Systematic Reviews doi
  119. (2009). Moosavi SH: Pharmacological treatment of refractory breathlessness. Expert Rev Resp Med doi
  120. (2003). NC: Inspiratory muscle training for asthma. Cochrane Database of Systematic Reviews doi
  121. (2002). Non-pharmacological treatment of breathlessness. doi
  122. (2003). Nurse specialist care for Bronchiectasis. Cochrane Database of Systematic Reviews doi
  123. (2005). Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  124. (2005). O’Neill B: Short-term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  125. (2005). Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  126. (2000). Oral methylxanthines for bronchiectasis. Cochrane Database of Systematic Reviews doi
  127. (2007). Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database of Systematic Reviews 2001, CD002162. Bailey et al. doi
  128. (2006). Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  129. (1993). Pearson C: The experience of dyspnoea in late stage cancer: patients’ and nurse perspectives. Cancer Nurs
  130. (2001). Pet allergen control measures for allergic asthma in children and adults. Cochrane Database of Systematic Reviews doi
  131. (2003). PG: High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. Cochrane Database of Systematic Reviews doi
  132. (2003). PG: Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database of Systematic Reviews doi
  133. (2005). PG: Macrolides for chronic asthma. Cochrane Database of Systematic Reviews doi
  134. (2002). PG: Options for self-management education for adults with asthma. Cochrane Database of Systematic Reviews doi
  135. (2005). Physical training for asthma. Cochrane Database of Systematic Reviews doi
  136. (2002). Physical training for bronchiectasis. Cochrane Database of Systematic Reviews doi
  137. (2006). Pollack MH: The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. doi
  138. (2007). Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database of Systematic Reviews doi
  139. (2001). Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database of Systematic Reviews doi
  140. (2002). PS: The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Education and Counselling doi
  141. (2006). Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  142. (2000). PW: Beclomethasone versus budesonide for chronic asthma. Cochrane Database of Systematic Reviews doi
  143. (2005). PW: Beclomethasone versus placebo for chronic asthma. Cochrane Database of Systematic Reviews doi
  144. (1999). PW: Budesonide versus placebo for chronic asthma in children and adults. Cochrane Database of Systematic Reviews doi
  145. (2005). PW: Corticosteroids for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews doi
  146. (2000). PW: Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database of Systematic Reviews doi
  147. (2005). PW: Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database of Systematic Reviews doi
  148. (2000). PW: Gold as an oral corticosteroid sparing agent in stable asthma. Cochran Database of Systematic Reviews doi
  149. (2003). PW: Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment. Cochrane Database of Systematic Reviews doi
  150. (2001). PW: Inhaled versus oral steroids for adults with chronic asthma. Cochrane Database of Systematic Reviews doi
  151. (2002). PW: Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  152. (2010). PW: Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax doi
  153. (2002). PW: Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. Cochrane Database of Systematic Reviews doi
  154. (2000). PW: Troleandomycin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database of Systematic Reviews doi
  155. (2004). R: Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials. BMC Pulm Med
  156. (2004). Ram FSF: Breathing exercises for asthma. Cochrane Database of Systematic Reviews doi
  157. (1998). Rowe BH: Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database of Systematic Reviews doi
  158. (2005). Rowe BH: Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews doi
  159. (2001). Rowe BH: Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database of Systematic Reviews doi
  160. (2002). RS: Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  161. (2007). RS: Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  162. (2004). Salvio F: Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database of Systematic Reviews doi
  163. (2002). Scano G: Is there a link between the qualitative descriptors and the quantitative perception of dyspnoea in asthma? Chest
  164. (2004). Seamark CJ: Living with severe chronic obstructive pulmonary disease: perceptions of patients and their carers. Pallit Med doi
  165. (2004). Selenium supplementation for asthma. Cochrane Database of Systematic Reviews doi
  166. (2003). Short acting beta2-agonists for bronchiectasis. Cochrane Database of Systematic Reviews doi
  167. (2006). Short-burst oxygen therapy in chronic obstructive pulmonary disease: Evidence-based review. Respir Med doi
  168. (2006). Shuldham CM: Psychological interventions for adults with asthma. Cochrane Database of Systematic Reviews doi
  169. (2004). Sildena l: Sildenafil for pulmonary hypertension. Cochrane Database of Systematic Reviews doi
  170. (2001). Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the lung cancer symptom scale in a community hospital. doi
  171. (2005). Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  172. (2000). The ‘needs of people with asthma’ survey and initial presentation of the data.
  173. (2002). The Acute Effects of Noninvasive Ventilatory Support During Exercise on Exercise Endurance and Dyspnea in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review. doi
  174. (2004). The dyspnea-anxiety-dyspnea cycle-COPD patients’ stories of breathlessness: “it’s scary/when you can’t breathe”. Qual Health Res doi
  175. (2006). The frequency and correlates of dyspnea in patients with advanced cancer. doi
  176. (2005). Understanding Dyspnoea by its language. doi
  177. (2004). Vitamin C supplementation for asthma. Cochrane Database of Systematic Reviews doi
  178. (2002). Walters EH: Limited (information only) patient education programs for adults with asthma. Cochrane Database of Systematic Reviews doi
  179. (2008). Wedzicha JA: Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  180. (2004). Wedzicha JA: Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi
  181. (2005). Wedzicha JA: Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database of Systematic Reviews doi
  182. (1999). Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax doi
  183. (2004). Where do we stand? Asthma in the UK today.
  184. (2008). World Health Organisation: World Health Statistics. doi
  185. (2002). Wouters EFM: Effects of physical activity in mild to moderate COPD: a systematic review.
  186. (2002). Zielhuis GA: Self management education for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.